transcranial direct current stimul… for Parkinson's (NCT06883266)
Reduce movement slowness and fatigue
- Trial ID
- NCT06883266
- Official Title
- Transcranial Direct Current Stimulation (tDCS) to Improve Motor Function and Motor Fatigue in Parkinson's Patients
- Goal
- Reduce movement slowness and fatigue
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Sanford Health
- Study Type
- INTERVENTIONAL
- Enrollment
- 64 participants
- Conditions
- Parkinsons Disease (PD)
- Interventions
- transcranial direct current stimulation (tDCS), Sham (No Treatment)
Summary For Families
The goal is to improve motor function and reduce motor fatigue in people with Parkinson's, targeting the slowness and tiring that make daily activities harder. It uses transcranial direct current stimulation, a gentle, noninvasive electrical current applied to the scalp to boost excitability in motor brain areas and help recalibrate the circuits that control movement; sessions are compared to sham (no treatment), and the approach is intended to be used alongside your usual Parkinson's medications rather than replace them. The trial is looking for adults with a clinical PD diagnosis who have at least two of the core motor signs and can consent, and it excludes people with dementia (MOCA < 21), deep brain stimulation, psychosis, multiple sclerosis, stroke, COPD, or congestive heart failure.
Locations
- Sanford Brain and Spine Center, Fargo, North Dakota, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying transcranial direct current stimulation (tDCS). The goal is to improve motor function and reduce motor fatigue in people with Parkinson's, targeting the slowness and tiring that make daily activities harder. It uses transcranial direct current stimulation, a gentle, noninvasive electrical current applied to the scalp to boost excitability in motor brain areas and help recalibrate the circuits that control movement; sessions are compared to sham (no treatment), and the approach is intended to be used alongside your usual Parkinson's medications rather than replace them. The trial is looking for adults with a clinical PD diagnosis who have at least two of the core motor signs and can consent, and it excludes people with dementia (MOCA < 21), deep brain stimulation, psychosis, multiple sclerosis, stroke, COPD, or congestive heart failure.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has 2 groups, and 1 is a sham (a pretend version of the procedure) group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the sham group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- 5 20-minute sessions, one each day for 5 consecutive days.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.